ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002
May 24, 2023 04:00 ET
|
AKAMPION
- First-in-class checkpoint inhibitor IOS-1002 (targeting LILRB1 (ILT2), LILRB2 (ILT4), KIR3DL1) being evaluated as mono and combination therapy in patients with advanced solid tumors Schlieren...
Monoclonal Antibodies Market Size & Share to Surpass $155.2 Billion by 2028 | Vantage Market Research
April 10, 2023 05:10 ET
|
Vantage Market Research
WASHINGTON, April 10, 2023 (GLOBE NEWSWIRE) -- The Global Monoclonal Antibodies Market is valued at USD 111.93 Billion in 2022 and is projected to reach a value of USD 186.67 Billion by 2030 at a...
BiondVax to Present at BIO-Europe Spring
March 16, 2023 13:10 ET
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, March 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing...
Biosimilars Market Size Worth ($136+ Billion by 2028) Lead by Intravenous Segment (36% CAGR) - Exclusive Research Study by The Insight Partners
February 27, 2023 07:39 ET
|
The Insight Partners
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Biosimilars Market Size, Share, Growth, Strategy & Global Forecast to 2028 - COVID-19 Impact and Global Analysis...
BioMed X Launches New T Cell Immunology Discovery Platform
February 14, 2023 06:00 ET
|
BioMed X Institute (990552)
HEIDELBERG, Germany, Feb. 14, 2023 (GLOBE NEWSWIRE) -- BioMed X announced today the launch of its new immunology discovery platform that will allow for the accurate and fast identification of target...
Injection Pen Market Size to Outstrip $60.33 Bn, Globally, by 2028 Growth Projections at 7.14% CAGR – Comprehensive Study by The Insight Partners
February 08, 2023 09:59 ET
|
The Insight Partners
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Injection Pen Market Size, Share, Growth and Global Forecast to 2028 - Global Analysis by Type (Disposable Injection...
ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002
January 17, 2023 04:00 ET
|
AKAMPION
- Lead compound IOS-1002 to be studied as mono and combination therapy in patients with advanced solid tumors- First patients to be enrolled in Q1, 2023 Schlieren (Zurich Area), Switzerland –...
BioMed X and AbbVie Extend Research Collaboration in the US
January 16, 2023 13:00 ET
|
BioMed X Institute
HEIDELBERG, Germany, Jan. 16, 2023 (GLOBE NEWSWIRE) -- BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie....
Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board
December 06, 2022 07:30 ET
|
BiondVax Pharmaceuticals Ltd.
Jerusalem, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing and commercializing...
Multiple Sclerosis Therapeutics Market Size Worth $39.22 Bn by 2027 – The Insight Partners
November 09, 2022 09:12 ET
|
The Insight Partners
New York, Nov. 09, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners new research study titled "Multiple Sclerosis Therapeutics Market Size, Share, Growth and Forecast to 2027 – COVID-19...